April 20, 2010 Andrew T. Weil MD Program Director Arizona Center for Integrative Medicine University of Arizona Dear Dr.

Weil, I'm writing you to in your capacity as a medical advisory board member of the Physicians Committee for Responsible Medicine (PCRM): http://www.pcrm.org/about/ I'm reporting about the relationship between your organization and your fellow PCRM board member, Dr. Henry J. Heimlich. I'd appreciate your answers to some quick questions. Before getting to my questions, here's some brief background. The April 8, 2010 LA Weekly published "Heimlich Maneuvered," an article about the controversy surrounding your organization's presentation of the "Henry J. Heimlich Award for Innovative Medicine": http://www.laweekly.com/2010-04-08/news/heimlich-maneuvered/ In both its mission statement and its IRS filings, the Washington, D.C.–based Physicians Committee for Responsible Medicine (PCRM) says it is "strongly opposed to unethical human research." But the group is throwing a private Hollywood Art of Compassion bash Sunday night to hand out a major award named after Dr. Henry Heimlich, who has been condemned by mainstream medical organizations around the world for his 20-year program of trying to cure cancer and AIDS by injecting people with malaria-infected blood. ...Neal Barnard founded PCRM in 1985, and still serves as president of the nonprofit organization, which has a $7.5 million annual budget and 35 paid staff. Barnard frequently appears on TV and radio as an advocate for animal rights in medical research. Barnard declined repeated requests for comment. The Beacon has reported extensively about the Heimlich "malariotherapy" experiments, including a recent item about the attached March 14, 2010 British Medical Journal article by investigative reporter Jeanne Lenzer. From Ms. Lenzer's report: For nearly 30 years, (Dr. Patrick's) career was intimately tied to the equally puzzling career of Henry Heimlich, once dubbed the “most famous physician in the world” for the life saving manoeuvre named after him. The two men worked tirelessly together, promoting the manoeuvre and later working on a cure for AIDS - a “cure” that was denounced by the US Centers for Disease Control and Prevention and the World Health Organization....Perhaps the most bizarre chapter of the Patrick-Heimlich alliance came when Heimlich became convinced that he could cure cancer, Lyme disease, and AIDS by infecting patients with malaria, known as “malariotherapy.” When the US Food and Drug Administration refused to allow the research to be conducted in the United States, the men moved the study to China, Ethiopia, and Gabon. The World Health Organization denounced the study as an example of “clearly unscrupulous and opportune research.” In 2003, the New York Times, Los Angeles Times, CNN/Reuters, and other news outlets reported about UCLA professors and the Heimlich "malariotherapy" experiments in China: http://bit.ly/cGcyEH


More about the Heimlich experiments in Africa from Radar Magazine, November 11, 2005: http://winston7.true.ws/ Mekbib Wondewossen is an Ethiopian immigrant who makes his living renting out cars in the San Francisco area, but in his spare time he works for Dr. Heimlich, doing everything from "recruiting the patients to working with the doctors here and there and everywhere," Wondewossen says. The two countries he names are Ethiopia and the small equatorial nation of Gabon, on Africa's west coast. "The Heimlich Institute is part of the work there - the main people, actually, in the research," Wondewossen says. "They're the ones who consult with us on everything. They tell us what to do." Wondewossen says that the project does not involve syringes full of malaria parasites. "We never induce the malaria," he says. "We go to an epidemic area where there is a lot of malaria, and then we look for patients that have HIV too. We find commercial sex workers or people who play around in that area." Such people are high-risk for HIV, and numerous studies show the virus makes its victims more vulnerable to malaria. A key to containing malaria is speedy treatment. In the most resource-poor areas, clinicians who lack the equipment necessary for diagnosing malaria will engage in presumptive treatment at the first signs of fever. This, says Wondewossen, runs contrary to Heimlich's interests. What physicians in Africa usually do "is terminate the malaria quickly when someone gets sick," he says. "But now we ask them to prolong it, and when we ask them to do that, the difference is very, very big." Untreated malaria is horrible and includes periods of 105-degree fever, excessive sweating followed by chills and uncontrollable shivering, blinding headaches, vomiting, body aches, anemia, and even dementia. Heimlich's malariotherapy literature recommends the patient go two to four weeks without treatment. Delay in treatment, warns the CDC, is a leading cause of death. Wondewossen say that the researchers involved in the study are not doctors. He refuses to name members of the research team, because he says it would get them into trouble with the local authorities. "The government over there is a bad government," he says. "They can make you disappear." Wondewossen won't reveal the source of funding for this malariotherapy research. "There are private funders," he says. But as to their identity? "I can't tell you that, because that's the deal we make with them, you know?" He scoffs at the question of whether his team got approval to conduct this research from a local ethics review board. Bribery on that scale, he says, is much too expensive: "If you want the government to get involved there, you have to give them a few million - and then they don't care what you do." Two years later, from the New Republic, April 23, 2007: http://www.tnr.com/article/politics/thechoke-artist (Dr. Heimlich) opened his last binder, which was marked confidential, and pulled out two sheets of paper. "Now I will tell you about the malariatherapy, or immunotherapy as we now call it, in Africa." He began to read from one of the sheets. "The Heimlich Institute has been collecting CD4 and viral load data on patients who are HIV-positive and have become infected with malaria. This data will provide support for the concept of using malariatherapy for treating HIV infection." The study involved the questionable practice of initially withholding treatment for malaria, so Heimlich would not tell me where in Africa this


new malariatherapy trial was being done. "You never know how the politicians will react in these countries," he explained. But, according to a public health physician who has worked on aids in East Africa and has knowledge of Heimlich's latest project, the study site is in Ethiopia...Still reading from the papers, Heimlich boasted about the study's early results. Six of the first seven HIV patients treated with malariatherapy, he claimed, had experienced decreases in their viral loads. Now he was eagerly anticipating results from the 42 other patients in the study. Finally, you may wish to review this June 8, 2007 ABC 20/20 report by Brian Ross "Dr. Heimlich's New 'Maneuver': Cure AIDS With Malaria": http://blogs.abcnews.com/theblotter/2007/06/dr_heimlichs_ne.html Dr. Barnard was featured in the ABC 20/20 report and wrote these two 2004 letters to newspapers in response to articles that discuss Dr. Heimlich's "malariotherapy" experiments: http://bit.ly/9cdcJW and http://bit.ly/bQV2TQ Further, your organization's website describes him as an expert in human research, so clearly he is thoroughly informed about the Heimlich "malariotherapy" experiments: http://www.pcrm.org/news/bios/research.html Thanks for reviewing the above material. Here are my questions: 1) When did you first become aware of the Heimlich "malariotherapy" experiments? 2) Per the above articles, the Heimlich Institute has been conducting "malariotherapy" research trials in a variety of countries for over two decades. Do you consider any of these experiments to be ethical? If so, which ones? 3) Do you see any disparity between the claim in PCRM's charter - "We oppose unethical human experiments" - and your organization's presentation of the "Heimlich Award"? If so, please explain. 4) Not long ago in this video interview, Dr. Heimlich told my colleague Justin Jeffre that he was making arrangements for new "malariotherapy" experiments to proceed in another country: http://bit.ly/dylI7I Do you have any comment? Please feel free to add any other comments you wish to offer. If you can get back to me this week, that would be great. If you anticipate needing more time to respond, could you please let me know? Thanks very much for your consideration and I look forward to receiving your reply. Sincerely, Jason A. Haap The Cincinnati Beacon


Date: Tue, 27 Apr 2010 00:04:30 -0400 From: Jason Haap, Cincinnati Beacon To: Richard Baxter (Business Mgr for Dr. Andrew Weil) CC: ghg@email.arizona.edu, cruzj@email.arizona.edu, dkerr@email.arizona.edu, ghumphre@email.arizona.edu Subject: Re: Fwd: Media Request for Dr. Weil Dear Mr. Baxter, I haven't received a response to my 4/20/10 inquiry to Dr. Weil: http://bit.ly/dgwNjV Given the seriousness of the issues, would you please advise when I may expect to receive Dr. Weil's answers to my questions? Thanks and looking forward to your reply. Sincerely, Jason Haap The Cincinnati Beacon


Sign up to vote on this title
UsefulNot useful